Application of sweat patch screening for 16 drugs and metabolites using a fast and highly selective LC-MS/MS method

Therapeutic Drug Monitoring

Volumn 36, Issue 1, 2014, Pages 35-45

  Koster, Remco A ^a   Alffenaar, Jan Willem C ^a   Greijdanus, Ben ^a   Vandernagel, Joanneke E L ^b,c   Uges, Donald R A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Tactus Addiction Treatment   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

drug monitoring; drugs of abuse; LC MS MS; qualifier quantifier ratios; sweat patches

Indexed keywords

2 ETHYLIDENE 1,5 DIMETHYL 3,3 DIPHENYLPYRROLIDINE; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMMONIUM FORMATE; AMPHETAMINE; BENZOYLECGONINE; COCAINE; CODEINE; COTININE; DIAMORPHINE; METHADONE; METHAMPHETAMINE; METHANOL; METHYLENEDIOXYETHYLAMPHETAMINE; METHYLPHENIDATE; MORPHINE; MORPHINE 6 ACETATE; NICOTINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DRUG ABUSE; DRUG SCREENING; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; PATCH TEST; PATIENT CARE; PH; PRIORITY JOURNAL; ROOM TEMPERATURE; SWEAT PATCH SCREENING; SWEAT TEST; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; HUMANS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; SWEAT; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84892937917     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182a04feb     Document Type: Article

References (33)

1. VanDerNagel J, Kiewik M, Van Dijk M, et al. Handleiding SumID-Q, Meetinstrument voor het in kaart brengen van Middelengebruik bij mensen met een lichte verstandelijke beperking. SumID-Q, Substance Use and Misuse in Intellectual Disability-Questionnaire. Deventer, The Netherlands: Tactus; 2011.
2. VanDerNagel JEL, Kiewik M, Jong CAJ, et al. Substance Use and Misuse Among Intellectually Disabled Persons (SUMID). Part of the ZonMW program: Risicogedrag en afhankelijkheid. 2008. Available at: http://www.zonmw.nl/nl/ projecten/project-detail/substance-use-and-misuse-amongintellectually-disabled- persons-sumid/samenvatting/.
3. Koster RA, Alffenaar JWC, Greijdanus B, et al. Fast and highly selective LC-MS/MS screening for THC and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse. Ther Drug Monit. In press.
4. Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta. 2006;370:17-49.
5. Kintz P, Marescaux C, Mangin P. Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring? Hum Exp Toxicol. 1995;14:812-815.
6. Takiguchi Y, Ishihara R, Torii M, et al. Hair analysis of flecainide for assessing the individual drug-taking behavior. Eur J Clin Pharmacol. 2002;58:99-101.
7. Sato H, Uematsu T, Yamada K, et al. Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol. Eur J Clin Pharmacol. 1993;44:439-444.
8. Liberty HJ, Johnson BD, Fortner N. Detecting cocaine use through sweat testing: multilevel modeling of sweat patch length-of-wear data. J Anal Toxicol. 2004;28:667-673.
9. Jaffee WB, Trucco E, Levy S, et al. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat. 2007;33:33-42.
10. Bush DM. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Forensic Sci Int. 2008;174:111-119.
11. Barnes AJ, Smith ML, Kacinko SL, et al. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. Clin Chem. 2008;54:172-180.
12. Brunet BR, Barnes AJ, Choo RE, et al. Monitoring pregnant women's illicit opiate and cocaine use with sweat testing. Ther Drug Monit. 2010; 32:40-49.
13. De Martinis BS, Barnes AJ, Scheidweiler KB, et al. Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852:450-458.
14. Fogerson R, Schoendorfer D, Fay J, et al. Qualitative detection of opiates in sweat by EIA and GC-MS. J Anal Toxicol. 1997;21:451-458.
15. Huestis MA, Cone EJ, Wong CJ, et al. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol. 2000;24:509-521.
16. Kacinko SL, Barnes AJ, Schwilke EW, et al. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clin Chem. 2005;51:2085-2094.
17. Kintz P, Tracqui A, Marzullo C, et al. Enantioselective analysis of methadone in sweat as monitored by liquid chromatography/ion spray-mass spectrometry. Ther Drug Monit. 1998;20:35-40.
18. Liberty HJ, Johnson BD, Fortner N, et al. Detecting crack and other cocaine use with fastpatches. Addict Biol. 2003;8:191-200.
19. Marchei E, Farre M, Pardo R, et al. Usefulness of sweat testing for the detection of methylphenidate after fast-and extended-release drug administration: a pilot study. Ther Drug Monit. 2010;32:508-511.
20. Marchei E, Farre M, Pellegrini M, et al. Liquid chromatography- electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices. J Pharm Biomed Anal. 2009;49:434-439.
21. Pichini S, Navarro M, Pacifici R, et al. Usefulness of sweat testing for the detection of MDMA after a single-dose administration. J Anal Toxicol. 2003;27:294-303.
22. Brunet BR, Barnes AJ, Scheidweiler KB, et al. Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal Bioanal Chem. 2008; 392:115-127.
23. Concheiro M, Shakleya DM, Huestis MA. Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2011;400:69-78.
24. The Commission of the European Communities, David Bryne. European Union decision. Off J Eur Communities. 2002;221:16.
25. Long M, Kidwell DA. Improving the PharmcheckTM Sweat Patch: Reducing False Positives From Environmental Contamination and Increasing Drug Detection. 2002. Document No.: 196030; Award Number: 2000-RD-CX-A038.
26. Kintz P, Henrich A, Cirimele V, et al. Nicotine monitoring in sweat with a sweat patch. J Chromatogr B Biomed Sci Appl. 1998;705:357-361.
27. Follador MJ, Yonamine M, de Moraes Moreau RL, et al. Detection of cocaine and cocaethylene in sweat by solid-phase microextraction and gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;811:37-40.
28. Kintz P, Brenneisen R, Bundeli P, et al. Sweat testing for heroin and metabolites in a heroin maintenance program. Clin Chem. 1997;43: 736-739.
29. Schwilke EW, Barnes AJ, Kacinko SL, et al. Opioid disposition in human sweat after controlled oral codeine administration. Clin Chem. 2006;52:1539-1545.
30. Kintz P, Tracqui A, Mangin P, et al. Sweat testing in opioid users with a sweat patch. J Anal Toxicol. 1996;20:393-397.
31. Marchei E, Farre M, Pellegrini M, et al. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject. Forensic Sci Int. 2010;196:59-63.
32. Kintz P. Drug testing in addicts: a comparison between urine, sweat, and hair. Ther Drug Monit. 1996;18:450-455.
33. Taylor JR, Watson ID, Tames FJ, et al. Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing. Addiction. 1998;93:847-853.